Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 5 (2008), Issue 2 (February)

1. A brain-specific decrease of the tyrosine hydroxylase protein in sepiapterin reductase-null mice--as a mouse model for Parkinson's disease.
   Biochem Biophys Res Commun, 367(4): 787-92. [Abstract] [Full-text]
2. Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase.
   Proc Natl Acad Sci U S A, 105(5): 1499-504. [Abstract] [Full-text]
3. The PINK1/Parkin pathway regulates mitochondrial morphology.
   Proc Natl Acad Sci U S A, 105(5): 1638-43. [Abstract] [Full-text]
4. Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.
   Proc Natl Acad Sci U S A, 105(5): 1716-21. [Abstract] [Full-text]
5. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease.
   Hum Mol Genet, 17(5): 759-67. [Abstract] [Full-text]
6. Fronto-striatal deficit in Parkinson's disease during semantic event sequencing.
   Neurobiol Aging, 29(3): 397-407. [Abstract] [Full-text]
7. Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia.
   Neurobiol Aging, 29(3): 379-96. [Abstract] [Full-text]
8. Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease.
   Am J Health Syst Pharm, 65(5): 414-9. [Abstract] [Full-text]
9. Should levodopa dose be reduced when switched to stalevo?
   Eur J Neurol, 15(3): 257-61. [Abstract] [Full-text]
10. LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.
    Eur J Neurol, 15(3): 301-5. [Abstract] [Full-text]
11. Does motor subtype influence neurocognitive performance in Parkinson's disease without dementia?
    Eur J Neurol, 15(3): 262-7. [Abstract] [Full-text]
12. Lateral stepping for postural correction in Parkinson's disease.
    Arch Phys Med Rehabil, 89(3): 492-9. [Abstract] [Full-text]
13. Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease.
    Arch Phys Med Rehabil, 89(3): 399-403. [Abstract] [Full-text]
14. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Basic Clin Pharmacol Toxicol, 102(3): 300-7. [Abstract] [Full-text]
15. An unusual case of misdiagnosed ventricular tachycardia.
    Emerg Med J, 25(3): 173-4. [Abstract] [Full-text]
16. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.
    J Neurochem, 104(6): 1504-25. [Abstract] [Full-text]
17. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study.
    Am J Epidemiol, 167(5): 553-60. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.